THE ACTION OF THE LETHAL DOSE OF STROPHANTHIN IN NORMAL ANIMALS AND IN ANIMALS INFECTED WITH PNEUMONIA.
Jamieson RA. · 1915
Read THE ACTION OF THE LETHAL DOSE OF STROPHANTHIN IN NORMAL ANIMALS AND IN ANIMALS INFECTED WITH PNEUMONIA. by Jamieson RA. (1915) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2125373.txt.
Introduction
Ross A. Jamieson asked in 1915 whether pneumonia changes the danger of the heart drug strophanthin, comparing lethal dosing in normal cats and dogs against pneumonic ones. Clinical worry said the infected heart might take the drug worse. The experiments say otherwise.
In cats the death rate after the standard dose was the same in both groups, though more cats survived than expected. The dose used was an average lethal dose drawn from earlier workers, whose actual injections had ranged widely. So animals needing more than the average naturally lived. Heart tracings agree: conduction delays and blocked auricular impulses appeared in both groups without pattern. Whether the uniformity carries to human pneumonia patients, Jamieson leaves open. Readers get a feared interaction tested head-on and found absent, with the dosing lesson attached.
Catalog record
| CREATOR | Jamieson RA. |
|---|---|
| YEAR | 1915 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| LICENSE | Public Domain |
| RIGHTS | PUBLIC DOMAIN |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
THE ACTION OF THE LETHAL DOSE OF STROPHANTHIN IN NORMAL ANIMALS AND IN ANIMALS INFECTED WITH PNEUMONIA By Ross A. Jamieson Published in: The Journal of Experimental Medicine DOI: 10.1084/jem.22.5.629 ABSTRACT The results of these experiments permit a comparison of the action of strophanthin in the normal and the infected animals. In cats the percentage of deaths following the injection of 0.1 mg. of strophanthin per kilo of body weight was the same in normal and in pneumonic cats. The number of recoveries in this series was larger than was expected. This result was due to the fact that the dose injected was not the lethal dose, but the average lethal dose (0.1 mg.) determined by Hatcher and Brody (7) and by Eggleston (8). The doses which the latter actually injected ranged from 0.085 rng. to 0.16 mg.; from these the average minimal lethal dose was calculated. In adopting the average dose as the standard one to inject, those of our cats that required more than 0.1 mg. naturally survived. The death rate was therefore low. The plan employed in dogs differed from that used in cats. A lethal dose was injected in each dog. Death occurred when an average of 0.12 mg. of strophanthin per kilo of body weight was injected. The same dose was required in normal and pneumonic dogs. The effect of strophanthin in both groups of infected and non-infected cats and dogs is, therefore, identical. Whether the uniformity of strophanthin action in the two experimental groups may serve as the basis for assuming a like uniformity of action in normal individuals and in pneumonia patients is a subject which requires further analysis. The difficulty in transferring the experimental results to patients lies in the question of whether the type of pneumonia produced in animals is the same as that found in man. Clinically, the two diseases present both resemblances and differences. The animals become definitely ill and show the symptoms already described. The illness, however, is of short duration and apparently reaches its height in the majority of animals in twenty-four to seventy-two hours. Before the expiration of this time, the temperature frequently returns to normal. Many of the infected animals, when they survive, recover in three to five days. The mortality in dogs infected with pneumococci is given by Lamar and Meltzer as 16 per cent. In the present series of twelve infected cats, the mortality was also 16 per cent. These findings differ from human pneumonia in the following particulars: The infection is not so severe; the temperature, though elevated at first, soon falls; the duration of the disease is short; and convalescence is rapid. The mortality is slightly lower. Musser and Norris (12) give the human mortality at 21.06 per cent. Pathologically the two diseases also show differences. The gross appearance of the lungs is not dissimilar, but in the animals the consolidated portions are somewhat dry and they fail to show a stage of gray hepatization (5). The amount of fibrin present is small. There is comparatively slight congestion of the alveolar walls and of the walls of the bronchi. The relation of experimental pneumonias to the human disease has been discussed by a number of investigators. Almost all believe that the two types are similar, if not identical. Among the first to express this opinion was Sternberg (13) ; and later Gamaleia (14), Prudden and Northrup (15), Kinyoun and Rosenau (16), Wadsworth (17), Lamar and Meltzer (5), Wollstein and Meltzer (9) coincided with his view. Lamar and Meltzer, especially, have insisted on the identity of the two processes. On the other hand, Welch (18) in his study of experimental pneumonia, says: "Many inoculations of cultures of virulent pneumococci into the trachea and lungs of dogs have been made in my laboratory by Dr. Canfield and myself, but in no instance were we able to produce an inflammation of the lungs which we were willing to identify with acute lobar pneumonia as found in human beings." But he adds that, in the majority of experiments, there was no demonstrable consolidation and that pleurisy and more or less extensive areas of pneumonia were produced only in a few animals. The inference consequently cannot be drawn that an effect obtained with strophanthin in the experimental disease may be anticipated in man. The striking similarity in action in infected and uninfected animals renders it likely, however, that the usual action of the drug in man may be expected in the presence of pneumonia. We have accumulated evidence, to be published later, which shows that this action actually takes place in the human disease. As far as evidence obtained electrocardiographically is concerned, our experiments show that strophanthin causes the same electrical changes in the heart when the animals are infected as it does under normal conditions. THE ACTION OF THE LETHAL DOSE OF STROPHAN- THIN IN NORMAL ANIMALS AND IN ANIMALS INFECTED WITH PNEUMONIA. BY ROSS A. JAMIESON, M.B. (From the Hospital of The Rockefeller Institute for Medical Research.) PLATES 74 TO 76. (Received for publication, July 15, 1915.) The following experiments were undertaken for the purpose of ascertaining whether the action of a digitalis body when adminis- tered to animals suffering from pneumonia differed from its action when no infection or fever was present. That there is a difference of opinion regarding the action of the drug when given in acute infections is shown in the practice of clinicians. For example, Mackenzie (I) doubts its value and says that digitalis "is often used when patients are dying of some grave affection, as pneumonia, as a last resort, probably more for the purpose of doing something than with expectation of great benefit. I have never seen much good follow the administration of digitalis in acute febrile states." Gibson (2) in his article on acute pneumonia also says, regarding the use of digitalis, that in the worst cases of pneumo- coccal poisoning the heart absolutely refuses to respond. On the other hand, in Krehl's clinic (3) digitalis is used in all cases of pneumonia with the belief that it has a beneficial effect. On account of this difference of opinion, Gunn (4) recently performed ex- periments with the view of determining what influence the height of the tem- perature has on the action of digitalis. In his experiments he perfused excised rabbits' hearts with solutions of strophanthin at different temperatures. The perfusion was carried to the point of arrest of the heart's action. By this pro- cedure Gunn demonstrated that with variations in temperature ranging from 28 to 41 C. strophanthin acts more quickly on the isolated heart as the tem- perature is raised. The conditions in Gunn's experiments are not analogous to those in pneumonia, since in the presence of this infection toxemia accompanies the increased temperature. In the experiments now reported the attempt was made to dupli- cate the usual human conditions as nearly as possible. A digitalis 629 630 Actio~t of Lethal Dose of Strophanthin i.~ Animals. body was administered to animals suffering from an acute pneu- monic infection and the effect compared with that obtained when the drug was given to healthy animals of the same species. A comparison of the results in